Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Taxes (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Current Taxes readings, the most recent being $722104.0 for Q1 2026.

  • On a quarterly basis, Current Taxes rose 21.36% to $722104.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $722104.0, a 21.36% increase, with the full-year FY2025 number at $718796.0, up 8.76% from a year prior.
  • Current Taxes hit $722104.0 in Q1 2026 for Pharma-Bio Serv, roughly flat from $718796.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.9 million in Q1 2022 to a low of $281702.0 in Q3 2022.
  • Median Current Taxes over the past 5 years was $660903.0 (2024), compared with a mean of $748639.1.
  • Biggest five-year swings in Current Taxes: skyrocketed 865.51% in 2022 and later crashed 73.59% in 2023.
  • Pharma-Bio Serv's Current Taxes stood at $337264.0 in 2022, then soared by 58.27% to $533782.0 in 2023, then rose by 23.82% to $660903.0 in 2024, then increased by 8.76% to $718796.0 in 2025, then rose by 0.46% to $722104.0 in 2026.
  • The last three reported values for Current Taxes were $722104.0 (Q1 2026), $718796.0 (Q4 2025), and $713153.0 (Q3 2025) per Business Quant data.